Determine the Antimetastasis Effect of Artesunate in Lung Cancer‐Driven Brain Metastasis Model
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2025. Verfasst von Minling Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Translational Cancer Research of Chinese Medicines, Joint International Research Laboratory of Translational C…. Hauptthemen laut MEDLINE: Artesunate, Lung Neoplasms, Brain Neoplasms. Die Arbeit nennt 34 Literaturangaben. Gefördert von: This study was supported by the National Natural Science Foundation of China, Project Number: 82274196, U22A20368; Open Project of the State Key Laboratory of….
Abstract (Originalsprache)
Brain metastasis (BM), most vital and common metastasis phenotype occurs during tumorigenesis, the incidence of which varied remarkedly in various cancers. Overwhelming evidence suggested blood–brain barrier (BBB) can attenuate the anti‐BM efficacy of chemotherapies via hindering their penetration. This study aimed to investigate the preferential cancer type that is more prone to BM, and bioactive compound that suppress BM through penetrating BBB. By intracardiac injection of lung cancer cells, breast cancer cells and melanoma cells, BM models were established. By two cycles of primary‐isolation and incubation of H446‐luc cells to improve the incidence of BM. Artemisinin (ART) and its derivatives were evaluated to suppress BM in vitro and in vivo. Compared to lung cancer‐driven BM (66.67%), the incidence of BM in breast cancer (16.67%–33.33%) and melanoma (33.33%) were extremely low. The incidence of BM in lung cancer increased from 66.67 (1st generation) to 80% (2nd generation). Compared to other ingredients, artesunate (ARTS) exerted a more significant inhibitory effect on cell proliferation, especially in lung cancer cells. Simultaneously, ARTS suppressed lung cancer migration via decreasing N‐cadherin and Snail, and enhancing E‐cadherin. Most importantly, we found that ARTS could strikingly suppress tumor growth in brain with high concentration, implying that ARTS might penetrate BBB and accumulate in brain tissue to hinder lung cancer‐driven BM. Our findings not only suggest lung cancer exhibited tumor specificity in cancer‐driven BM model, but also provide ARTS as a promising candidate for clinical treatment of lung cancer‐relayed BM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Translational Cancer Research of Chinese Medicines, Joint International Research Laboratory of Translational Cancer Research of Chinese Medicines, State Key Laboratory of Tradition…
- Chinese Medicine Guangdong Laboratory (Hengqin Laboratory), Hengqin, Guangdong, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, SAR, China.
- Department of Cardiothoracic Surgery, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
ORCID-Profile: Linlin Lu
Förderung
- This study was supported by the National Natural Science Foundation of China, Project Number: 82274196, U22A20368; Open Project of the State Key Laboratory of…
Zitieren
APA
Lu, M., Wan, T., Huang, Q., Yao, J., Zheng, Y., Yu, S., Zhu, X., Zeng, X., Liu, Z., Zheng, Y., & Lu, L. (2025). Determine the Antimetastasis Effect of Artesunate in Lung Cancer‐Driven Brain Metastasis Model. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70010
Vancouver
Lu M, Wan T, Huang Q, Yao J, Zheng Y, Yu S, et al. Determine the Antimetastasis Effect of Artesunate in Lung Cancer‐Driven Brain Metastasis Model. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70010
BibTeX
@article{Lu2025,
author = {Lu, Minling and Wan, Ting and Huang, Qianling and Yao, Jingjing and Zheng, Yaqiu and Yu, Shaofang and Zhu, Xiaomin and Zeng, Xiaoyi and Liu, Zhongqiu and Zheng, Yuan and Lu, Linlin},
title = {Determine the Antimetastasis Effect of Artesunate in Lung Cancer‐Driven Brain Metastasis Model},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.70010}
}
EUVIMED